Shares of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) continue to surge following commercial availability of Iclusig and the UK Daily Mail’s report on a potential buyout. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) stock opened at $7.37 in last session, and closed at $8.99, while the day range of stock is $7.35 – $9.83. The stock showed a positive weekly performance of 33.38%.
Emerging markets are once more front and center after the iShares MSCI Emerging Markets Indx (ETF) (NYSEARCA:EEM) dropped 3.9% last week, its largest one-week decline since last June. Funds devoted to Chile, Turkey, and Brazil, meanwhile, fell more than 5% last week as investors headed for the exit. Sure, that looks a lot like the turmoil that hit emerging markets last year, when global interest rates started to rise after the Federal Reserve broached the topic of curtailing its bond purchases. iShares MSCI Emerging Markets Indx (ETF) (NYSEARCA:EEM) stock opened at $38.75, in last session and closed at $38.24, by losing -2.60%. The 52 week range of the stock is $36.16 – $44.64. Company’s market capitalization is $35.83 billion.
The best 30 year FRM interest rates at Bank of America (NYSE:BAC) are being quoted at 4.375% carrying an APR of 4.505%. 15 year loans at the bank are being quoted at 3.625% with an APR of 3.796%. Bank of America Corp (NYSE:BAC) stock decreased -2.43% and finished the last session at $16.45. The EPS of the stock remained 0.89. Company’s market capitalization is $174.24 billion.
General Electric Company (NYSE:GE) Director William G. Beattie bought 2,000 shares of General Electric stock on the open market in a transaction that occurred on Friday, January 24th. The shares were purchased at an average cost of $25.47 per share, for a total transaction of $50,940.00. General Electric Company (NYSE:GE) stock opened the session at $25.57, and closed the session at $24.95. The 52 week range of the stock remained $21.11 – $28.09 and the day range was $24.95 – $25.59.